Methylated Biomarkers Predictive of Endometrial Cancer Risk

NCT06800677 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-01-30

No results posted yet for this study

Summary

The goal of this observational study is to identify endometrial cancer risk predictive biomarkers and to optimise the methodology for their detection and quantification in non-invasive samples.

Conditions

Interventions

PROCEDURE

Hysterectomy

Elective hysterectomy

Sponsors & Collaborators

  • Queen Mary University of London

    collaborator OTHER
  • University of Manchester

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-31
Primary Completion
2026-06-30
Completion
2026-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06800677 on ClinicalTrials.gov